Inflammatory Bowel Disease Clinical Trial
Official title:
A Randomized, Controlled, Single-blind Study of Effects of Pectin on Flora Intestinal Colonization and Maintenance After Fecal Transplantation to Patients With Inflammatory Bowel Disease
The purpose of this study is to evaluate the effect and safety of pectin and fecal microbiota transplantation on patients with inflammatory bowel disease. The investigators hypothesize that patients who take pectin can promote the migration of probiotics in intestine engraftment, reduce pathogenic agents'adhesion to intestinal mucosa, cut down the inflammation, and to maintain intestinal flora diversity and steady state in a long time.
Inflammatory bowel disease (IBD) is a chronic relapsing disease, including ulcerative
colitis (UC) and Crohn's disease (CD). Although the etiology of IBD is unknown, but more and
more evidence show that the inappropriate immune response to intestinal commensal bacteria
leading to dysbiosis, and pathogens further act to the mucosal lymphoid tissue, causing IBD.
Has yet not to determine the specific one or more pathogens as the cause of IBD,but
literatures confirm the changes of diversity of the intestine flora.Based on the current
awareness of changes in the intestinal flora in IBD, fecal microbiota transplantation (FMT)
proposed in recent years to rebuild the intestine flora balance to achieve therapeutic
purposes. But fecal bacteria of patients can not consistent with donor's for a long term
after transplantation and therefore it is not an ideal way for disease control. Maintaining
the diversity of flora in a long time so that well controlled the disease become the
breakthrough of fecal microbiota transplantation in the treatment of inflammatory bowel
disease.
Pectin is a soluble dietary fiber (DF), produced by the gut flora after a series of
fermentation with many metabolites such as short chain fatty acids (SCFA) which supply the
energy for epithelial cells, regulate intestinal PH and intestinal motility and join effort
in immune regulation with intestinal lymphoid tissue. Previous studies showed that:
water-soluble dietary fiber with the action of intestinal flora can cut the inflammatory
cytokines, prevent inflammation and induce regulatory T cells, but the type and dose of
dietary fiber used were different in different studies, and no studies have confirmed
whether dietary fiber could adjusted the flora colonization ability in patients with IBD. We
conceive that pectin by some mechanism to promote the migration of probiotics in intestine
engraftment, reduce pathogenic agents' adhesion of intestinal mucosa, cut inflammation, and
to maintain intestinal flora diversity and steady state in a long time, and than achieve the
goal of continue to ease IBD.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03278912 -
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
|
||
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05579392 -
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
|
N/A | |
Completed |
NCT03264690 -
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
|
||
Recruiting |
NCT02861053 -
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
|
N/A | |
Recruiting |
NCT02275676 -
Resting Energy Expenditure and Nutritional Status in IBD
|
N/A | |
Completed |
NCT02161640 -
Vascular Dysfunction in Paediatric IBD
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT01852760 -
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
|
N/A | |
Completed |
NCT01933867 -
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
|
N/A | |
Completed |
NCT01688557 -
Trial on Innovative Technologies in Colonoscopy
|
N/A | |
Completed |
NCT01692743 -
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
|
Phase 3 | |
Completed |
NCT01666535 -
Infliximab IBD Influenza Vaccine Study
|
N/A | |
Completed |
NCT01676324 -
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01557387 -
Real-time Diagnosis of Pseudopolyps During Colonoscopy
|
||
Completed |
NCT01981616 -
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
|
Phase 1 | |
Completed |
NCT01221818 -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A |